BIOMAT Database Logo BIOMAT Database Logo

Isolation and biochemical characterization of a new topoisomerase I inhibitor from Ocotea leucoxylon. 2000

B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061-0212, USA.

In a continuation of our search for potential tumor inhibitors from plants, we found that a crude extract from Ocotea leucoxylon showed selective activity typical of inhibitors of the enzyme topoisomerase I in a yeast assay for DNA-damaging agents. Using a bioassay-directed fractionation approach, the major bioactive compound was isolated and identified as the known aporphine alkaloid dicentrinone (4); the inactive alkaloid dicentrine (3) was also isolated. Compound 4 showed selective bioactivity against the rad52 repair-deficient yeast strain RS322 (IC(12) 49 microg/mL) and was inactive against the rad52- and topo1-deficient strain RS321 (IC(12) > 2000 microg/mL) and against the repair-proficient strain RJ03 (IC(12) > 2000 microg/mL). Biochemical studies with recombinant human topoisomerase I indicated that dicentrinone (4) is an inhibitor of the human enzyme. Colony formation studies suggest that it is weakly cytotoxic, but that its mechanism of toxicity differs from that of camptothecin and its derivatives.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004278 DNA, Superhelical Circular duplex DNA isolated from viruses, bacteria and mitochondria in supercoiled or supertwisted form. This superhelical DNA is endowed with free energy. During transcription, the magnitude of RNA initiation is proportional to the DNA superhelicity. DNA, Supercoiled,DNA, Supertwisted,Supercoiled DNA,Superhelical DNA,Supertwisted DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001060 Aporphines Dibenzoquinolines derived in plants from (S)-reticuline (BENZYLISOQUINOLINES).
D012441 Saccharomyces cerevisiae A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement. Baker's Yeast,Brewer's Yeast,Candida robusta,S. cerevisiae,Saccharomyces capensis,Saccharomyces italicus,Saccharomyces oviformis,Saccharomyces uvarum var. melibiosus,Yeast, Baker's,Yeast, Brewer's,Baker Yeast,S cerevisiae,Baker's Yeasts,Yeast, Baker
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass

Related Publications

B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
A new topoisomerase-II inhibitor, BE-10988, produced by a streptomycete. I. Taxonomy, fermentation, isolation and characterization.
May 1991, The Journal of antibiotics,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Biochemical characterization of topoisomerase I purified from avian erythrocytes.
May 1983, Nucleic acids research,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Drosophila topoisomerase I: isolation, purification and characterization.
November 1982, Nucleic acids research,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor.
September 1993, Annals of oncology : official journal of the European Society for Medical Oncology,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Asperaldin, a new aldose reductase inhibitor from Aspergilus niger CFR-1046. I. Fermentation, isolation and characterization.
February 2003, The Journal of antibiotics,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor.
May 1996, British journal of cancer,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Antibiotic GE37468 A: a new inhibitor of bacterial protein synthesis. I. Isolation and characterization.
August 1995, The Journal of antibiotics,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Isolation and biochemical characterization of a new NADH oxidase from Lactobacillus brevis.
January 2003, Biotechnology letters,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Isolation and characterization of proteinase inhibitor I from etiolated tobacco leaves.
May 1984, Archives of biochemistry and biophysics,
B N Zhou, and R K Johnson, and M R Mattern, and X Wang, and S M Hecht, and H T Beck, and A Ortiz, and D G Kingston
Isolation and characterization of a new trypsin inhibitor from Crotalaria paulina seeds.
November 1999, IUBMB life,
Copied contents to your clipboard!